½ûÂþÌìÌÃ

Venture

Illumina Buys Out Big Investors With $8B Acquisition Of Grail

Gene sequencing firm announced plans on Monday to buy cancer screening startup in a cash-and-stock deal worth $8 billion.

Subscribe to the ½ûÂþÌìÌà Daily

Grail (Nasdaq: GRAL) was founded in 2016 by San Diego-based Illumina as a separate company and had raised about $2 billion, with investors including Amazon’s Jeff Bezos and  co-founder Bill Gates. The deal comes weeks after Grail filed to go public.

Illumina (Nasdaq: ILMN) is Grail’s largest shareholder, holding a 14.5 percent stake. Grail stockholders, including Illumina, will receive $3.5 billion in cash and $4.5 billion in shares of Illumina stock, on Monday.

Illustration: .

Stay up to date with recent funding rounds, acquisitions, and more with the ½ûÂþÌìÌà Daily.

67.1K Followers

CTA

Discover and act on private market opportunities with predictive company intelligence.

Copy link